Your browser doesn't support javascript.
loading
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma.
Vincenzi, Bruno; Stacchiotti, Silvia; Collini, Paola; Pantano, Francesco; Rabitti, Carla; Perrone, Giuseppe; Iuliani, Michele; Baldi, Alfonso; Badalamenti, Giuseppe; Sanfilippo, Roberta; Santini, Daniele; Muda, Andrea Onetti; Gronchi, Alessandro; Casali, Paolo; Dei Tos, Angelo Paolo; Tonini, Giuseppe.
Affiliation
  • Vincenzi B; Medical Oncology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Stacchiotti S; Sarcoma Unit Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.
  • Collini P; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
  • Pantano F; Medical Oncology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Rabitti C; Human Pathology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Perrone G; Human Pathology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Iuliani M; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Via A. Vivaldi 43, 81100 Caserta, Italy.
  • Baldi A; Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, Second University of Naples, Via A. Vivaldi 43, 81100 Caserta, Italy.
  • Badalamenti G; Department of Surgical and Oncological Sciences, University of Palermo, Via del Vespro 131, 90127 Palermo, Italy.
  • Sanfilippo R; Sarcoma Unit Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.
  • Santini D; Medical Oncology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Muda AO; Human Pathology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy.
  • Casali P; Sarcoma Unit Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.
  • Dei Tos AP; Department of Pathology and Molecular Genetics, Treviso General Hospital, Piazza Ospedale 1, 31100 Treviso, Italy.
  • Tonini G; Medical Oncology, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 200, 00128 Rome, Italy.
Br J Cancer ; 117(3): 340-346, 2017 Jul 25.
Article in En | MEDLINE | ID: mdl-28641307
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Equilibrative Nucleoside Transporter 1 / Deoxycytidine / Leiomyosarcoma / Hemangiosarcoma / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2017 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Equilibrative Nucleoside Transporter 1 / Deoxycytidine / Leiomyosarcoma / Hemangiosarcoma / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2017 Document type: Article Affiliation country: Country of publication: